Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Page 2 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2020-07-02
ADIAL PHARMACEUTICALS, INC.
Registered companyEffectiveCIK 1513525
 S-1Registration filed0001213900-20-016605
2020-06-10
ADIAL PHARMACEUTICALS, INC.
ShelfEffectiveCIK 1513525
 424B5Shelf takedown0001213900-20-014598
2020-04-30
ADIAL PHARMACEUTICALS, INC.
ShelfEffectiveCIK 1513525
 EFFECTDeclared effective9999999995-20-000938
2020-04-27
ADIAL PHARMACEUTICALS, INC.
Registered companyFinal prospectusCIK 1513525
 EFFECTDeclared effective9999999995-20-000871
2020-04-27
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 EFFECTDeclared effective9999999995-20-000864
2020-04-22
ADIAL PHARMACEUTICALS, INC.
ShelfEffectiveCIK 1513525
 S-3Shelf registered0001213900-20-009839
2019-04-01
ADIAL PHARMACEUTICALS, INC.
Registered companyEffectiveCIK 1513525
 EFFECTDeclared effective9999999995-19-000565
2019-03-29
ADIAL PHARMACEUTICALS, INC.
Registered companyEffectiveCIK 1513525
 S-1/AAmendment0001213900-19-005164
2019-03-22
ADIAL PHARMACEUTICALS, INC.
Registered companyEffectiveCIK 1513525
 S-1Registration filed0001213900-19-004699
2019-02-22
ADIAL PHARMACEUTICALS, INC.
Registered companyFinal prospectusCIK 1513525
 424B4Final prospectus0001213900-19-003016
2019-02-20
ADIAL PHARMACEUTICALS, INC.
Registered companyFinal prospectusCIK 1513525
 EFFECTDeclared effective9999999995-19-000305
2019-02-19
ADIAL PHARMACEUTICALS, INC.
Registered companyFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-19-002771
2019-02-12
ADIAL PHARMACEUTICALS, INC.
Registered companyFinal prospectusCIK 1513525
 S-1Registration filed0001213900-19-002177
2019-01-07
ADIAL PHARMACEUTICALS, INC.
CIK 1513525
 DRSDraft made public0001213900-19-000233
2018-07-30
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 424B4Final prospectus0001213900-18-009822
2018-07-26
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 EFFECTDeclared effective9999999995-18-002166
2018-07-26
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 EFFECTDeclared effective9999999995-18-001892
2018-07-10
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-18-008954
2018-07-03
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-18-008645
2018-06-26
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-18-008185
2018-06-11
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-18-007448
2018-04-16
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-18-004479
2017-11-22
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-17-012521
2017-10-25
ADIAL PHARMACEUTICALS, INC.
IPOFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-17-010930
2017-09-25
ADial Pharmaceuticals, L.L.C.
IPOFinal prospectusCIK 1513525
 S-1/AAmendment0001213900-17-009973
2017-09-07
ADial Pharmaceuticals, L.L.C.
IPOFinal prospectusCIK 1513525
 S-1Registration filed0001213900-17-009468
2017-05-12
Adial Pharmaceuticals, L.L.C.
CIK 1513525
 DRSDraft made public0001213900-17-005075
← Newer